REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Bolt Biotherapeutics Inc. (BOLT) on Thursday reported a loss of $6.6 million in its fourth quarter.
The Redwood City, California-based company said it had a loss of $3.84 per share.
The company posted revenue of $2.5 million in the period.
For the year, the company reported that its loss narrowed to $33.4 million, or $17.85 per share. Revenue was nearly unchanged at $7.7 million.
In the final minutes of trading on Thursday, the company’s shares hit $4.10. A year ago, they were trading at $8.06.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BOLT at https://www.zacks.com/ap/BOLT
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
